Exclusive interview with Cryoport CEO - Gasworld

April 10, 2018

Gasworld spoke to Jerry Shelton, Cryoport’s CEO, to find out how the latest regenerative medicines wouldn’t be possible without an often overlooked, yet extremely important component: logistics.s. 

Inside the Company Delivering the Next Generation of Cancer Therapies - Wired Magazine

March 05, 2018

When it comes to shipping CAR-T cells, there are many factors that come in to play in order for drug companies to successfully mitigate risk – that’s where Cryoport comes in. Check out a recent...

The Logistics Behind Personalized Medicine Delivery - Contract Pharma Article

February 21, 2018

Cryoport serves the biopharmaceutical market with leading-edge logistics solutions for biologic materials to ensure a safe delivery, such as regenerative medicine, including immunotherapies, stem...

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment - Pharmaceutical Outsourcing

February 12, 2018

"Emerging technologies such as regenerative medicine will only increase the complexity of the logistics systems that need to be validated, especially as the requirements of the Drug Supply Chain...

CAR-T Supply Chain Logistics - Contract Pharma Article

November 06, 2017

"This past August, the FDA approved the first chimeric antigen receptor T cell (CAR-T) immunotherapy, Novartis’ Kymriah for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL). It...

Cryogenic Logistics Company Cryoport Grabs Contracts for Gilead, Novartis CAR-T Products - BioSpace Article

November 03, 2017

"In the world of developing and manufacturing cell-based therapeutics an approved medication for any indication is only part of the business plan. The other aspect is delivering the product to...

Intelligent Logistics: Key Considerations of Manufacturing Biologics

September 21, 2017

The pharmaceutical industry faces many challenges when manufacturing biologics in a commercial environment. Since manufacturing is being increasingly outsourced, cell bank production, maintenance...

Cold Chain Market and Technology Trends

September 06, 2017

The cold chain pharmaceutical market continues to be one garnering specific interest within the logistics space. New therapies such as regenerative therapies and gene therapies as well as a shift...

The Arrival of Quality by Design in Logistics

April 25, 2017

Quality by Design (QbD) is a concept that has become mainstream in the pharmaceutical manufacturing space in recent years. The QbD concept within cryogenic logistics cannot be implemented without...

Packaging, IT and Cold Chain Logistics Advances for the Future of Medicine and Clinical Trials

March 01, 2017

Many industry experts believe the most significant advancement for the future of medicine and clinical trials logistics is the realization that logistics has a direct and measurable scientific...

Risky Move

February 24, 2017

When transporting temperature-sensitive regenerative therapies, companies can mitigate risk by employing a Supply Chain Quality by Design (SC-QbD) process during clinical and commercial...

Biostorage: Closing the Loop in Biopharmaceutical Supply Chain Management

January 03, 2017 The complexity of shipping and storing temperature-sensitive biologics creates cold chain challenges. However, these risks can be mitigated when advanced packaging, data monitoring and biostorage...

IT and Logistics Solutions for Animal Vaccine Distribution

December 07, 2016

Animal vaccines are essential, not just because they can effectively prevent potentially serious diseases in animals, but also they can be beneficial to humans’ health. In an International Journal...

Cold Chain Planning: An Integrated Approach

December 03, 2016

CAR T-cell therapy, immunotherapy and other autologous cellular therapies require an integrated approach for their manufacture, shipment and storage. The need for integration is largely due to the...

Logistics Advancements and Trends in the Biopharma Industry

December 01, 2016

For successful commercial distribution, advanced cellular therapies require secure, well-designed cold chain management solutions based on effective packaging, informatics and logistics expertise....

Cold Chain Challenges Evolving With Industry

November 23, 2016

To ensure the safety and efficacy of inherently fragile regenerative medicines and other temperature-sensitive clinical trial therapeutics and biospecimens, the materials must be maintained within...

Cold Chain Planning for Regenerative Medicine Clinical Studies

November 01, 2016

The advent of regenerative therapy — a field that includes gene therapy, gene editing, stem cell therapy and immuno-oncology — is creating an unprecedented need for cold chain logistics. According...

It’s Never Too Early for Cold Chain Planning for Cellular Therapies

October 01, 2016 New cellular therapies underscore the complexity of cold chain logistics with new requirements that may be unfamiliar to even experienced supply chain managers. Writing in Applied Clinical Trials,

The Complexity of Cold Chain Logistics

September 08, 2016 Cell and gene therapy is now considered “the third pillar” of health care — along with traditional pharmaceuticals and biologic drugs. One critical challenge in the commercialization of cell and...

Cryoport Launching Logistics Study for Bioanalytical and Clinical Trial Materials

August 30, 2016 Cryoport launched a study examining the effects of temperature and transport packaging on biomarkers and cell-therapy cancer vaccines. Currently, little research has examined shipping conditions’...

CenterWatch Interview: Cryoport’s Chief Commercial Officer, Mark W. Sawicki, Ph.D., on a New Era of Logistics Challenges

August 22, 2016 Logistics, and particularly cold chain logistics, has taken an increasingly important role in the development of new therapeutics. With the advent of regenerative medicines and personalized...

Cryoport to Convert Life Science Shipping Logistics For Contract Manufacturer

August 06, 2016 Cryoport continues to grow with the recent signing of an agreement with a leading contract biopharmaceutical supplier to convert its current fleet of liquid nitrogen (LN2) dewars to Cryoport’s...

Supply Chain Challenges with New Therapies

July 07, 2016

Supply chains for many regenerative therapies can be very complex. Where traditional pharmaceuticals have linear supply chain models, autologous cell therapies oftentimes require circular supply...

The Best Chance of Delivery for Life-Giving Shipments

June 21, 2016

As Asia’s pharmaceutical and biopharmaceutical industries grow, the infrastructure, supply chain management and logistics management challenges necessitate innovation. The need for proper shipping...

Cryogenic Gas Solutions Drive Regenerative Therapies in Life Sciences

June 06, 2016

Innovation in the pharmaceutical industry is being led by regenerative therapies. Many of these new therapies need to be maintained at cryogenic conditions during storage and transport and cannot...